@article{c55912c8ce9e450fbe5f85157b80455d,
title = "Structures of Gating Intermediates in a K+ channell",
abstract = "Regulation of ion conduction through the pore of a K+ channel takes place through the coordinated action of the activation gate at the bundle crossing of the inner helices and the inactivation gate located at the selectivity filter. The mechanism of allosteric coupling of these gates is of key interest. Here we report new insights into this allosteric coupling mechanism from studies on a W67F mutant of the KcsA channel. W67 is in the pore helix and is highly conserved in K+ channels. The KcsA W67F channel shows severely reduced inactivation and an enhanced rate of activation. We use continuous wave EPR spectroscopy to establish that the KcsA W67F channel shows an altered pH dependence of activation. Structural studies on the W67F channel provide the structures of two intermediate states: a pre- open state and a pre-inactivated state of the KcsA channel. These structures highlight key nodes in the allosteric pathway. The structure of the KcsA W67F channel with the activation gate open shows altered ion occupancy at the second ion binding site (S2) in the selectivity filter. This finding in combination with previous studies strongly support a requirement for ion occupancy at the S2 site for the channel to inactivate.",
keywords = "Channel gating, Crystallography, Electrophysiology, Membrane protein, Potassium channel",
author = "Ravikumar Reddi and Kimberly Matulef and Erika Riederer and Pierre Moenne-Loccoz and Valiyaveetil, {Francis I.}",
note = "Funding Information: We thank Dr. Roderick MacKinnon for providing the KcsA plasmid and the KcsA monoclonal antibody expressing hybridoma cells. We thank Dr. Eric Gouaux for providing access to crystallization equipment. Crystallography data were collected at GM/CA beamline 23ID-B at the Advanced Photon Source (APS) at Argonne National Laboratory and at beamline 4.2.2 at the Advanced Light Source (ALS). We thank the staff at the beamlines for their support with data collection. GM/CA @ APS has been funded in whole or in part with Federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Use of APS was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-ENG-38. Beamline 4.2.2 of the Advanced Light Source, a U.S. DOE Office of Science User Facility under Contract No. DE-AC02-05CH11231, is supported in part by the ALS-ENABLE program funded by the National Institutes of Health, National Institute of General Medical Sciences, grant P30 GM124169-01. This research was supported by a grant from the National Institute of General Medical Sciences (R01GM087546) of the National Institutes of Health to FIV. EAR was supported by a pre-doctoral fellowship from the American Heart Association (AHA 19PRE34380950). The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Funding Information: We thank Dr. Roderick MacKinnon for providing the KcsA plasmid and the KcsA monoclonal antibody expressing hybridoma cells. We thank Dr. Eric Gouaux for providing access to crystallization equipment. Crystallography data were collected at GM/CA beamline 23ID-B at the Advanced Photon Source (APS) at Argonne National Laboratory and at beamline 4.2.2 at the Advanced Light Source (ALS). We thank the staff at the beamlines for their support with data collection. GM/CA @ APS has been funded in whole or in part with Federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Use of APS was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-ENG-38. Beamline 4.2.2 of the Advanced Light Source, a U.S. DOE Office of Science User Facility under Contract No. DE-AC02-05CH11231, is supported in part by the ALS-ENABLE program funded by the National Institutes of Health, National Institute of General Medical Sciences, grant P30 GM124169-01. This research was supported by a grant from the National Institute of General Medical Sciences (R01GM087546) of the National Institutes of Health to FIV. EAR was supported by a pre-doctoral fellowship from the American Heart Association (AHA 19PRE34380950). Publisher Copyright: {\textcopyright} 2021 Elsevier Ltd",
year = "2021",
month = nov,
day = "19",
doi = "10.1016/j.jmb.2021.167296",
language = "English (US)",
volume = "433",
journal = "Journal of Molecular Biology",
issn = "0022-2836",
publisher = "Academic Press Inc.",
number = "23",
}